CFTC Wins Case Against Crypto Fund Operators
July 3, 2024
Investing.com - Sarepta Therapeutics (NASDAQ:), a pioneer in precision genetic medicine for rare diseases, surged in Thursday's after-hours deals after ...
ROCKVILLE, MD and SHENZHEN, CHINA, Jun 5, 2024 - (ACN Newswire) - - HighTide Therapeutics, Inc. (HKEX: 2511), a clinical ...
Exploration Capital, LLC, a significant shareholder in Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX), has recently purchased additional shares of the company, ...
Vivos Therapeutics, a company specializing in the treatment of obstructive sleep apnea (OSA), reported a total revenue of $3.4 million ...
On Thursday, Northland Securities sustained their Outperform rating on Heron Therapeutics (NASDAQ:) with a steady price target of $9.00. The ...
On Thursday, an analyst from H.C. Wainwright adjusted the price target for Fate Therapeutics (NASDAQ:) shares, a clinical-stage biopharmaceutical company, ...
Fulcrum Therapeutics (ticker: NASDAQ:) has entered into a significant collaboration with Sanofi (NASDAQ:) for the development and commercialization of losmapimod, ...
In a recent transaction, Steven Keith Burke, the Senior Vice President and Chief Medical Officer of Akebia Therapeutics, Inc. (NASDAQ:), ...
© Reuters. Tuesday - RBC Capital Markets has initiated coverage on shares of Applied Therapeutics (NASDAQ:), bestowing an Outperform rating ...
© Reuters. Stoke Therapeutics, Inc. (NASDAQ:) has reported a recent sale of shares by CFO Stephen J. Tulipano, according to ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.